Quality & risk control
Design focused on process reliability, materials and contamination management, and consistency with good practice in regulated environments.
Deep tech · bio-pharma · IP
A patented platform for a demanding market
Inov4D addresses bio-pharma — where quality and traceability drive purchasing — with a 3D printer built around a patented micropump. Software and AI deliver process control: a durable product and software trajectory beyond hardware alone. We are engaging with investors who share that long-term view.
Why invest
This is not a consumer 3D printer: we target a market where compliance, data, and reproducibility drive budgets. The combination of patent + software, AI, and SaaS (recipes, traceability) creates differentiated, defensible value over time.
- Intellectual property — patented micropump: a technology base that stands apart from generic offerings and supports long-term positioning.
- Target market — R&D, prototyping, and controlled environments: buyers where quality risk and traceability are purchase criteria, not extras.
- Software & AI — process control, optimization, and data: recurring value levers and ongoing differentiation.
- SaaS — recipes & traceability — print recipe management (versioned parameters), data chain, and traceability of produced parts—beyond the hardware alone.
- Integrated platform — co-designed mechanics, electronics, and software for a traceable, scalable chain aligned with sector protocols.
- Industry validation — co-development with pharma, biotech, and equipment partners: market grounding and product-market fit.
Technical credibility
- Sterility — no cross-contamination between fluids.
- Single- or dual-component — supports one- or two-component processes.
- Precision — 0.01 ml dosing and 0.1% accuracy for mixtures.
- Compact size — small footprint for integration in the lab or in a controlled line.
Market & opportunity
Biopharma invests heavily in innovation and process quality. Equipment that serves R&D while supporting paths toward qualified environments is scarce — that is the positioning Inov4D pursues: systems that meet sector expectations with a clear product trajectory.
Risk-aware, sector-grade expectations
For investors, risk clarity matters: our development rests on three pillars aligned with typical bio-pharma project needs — without claiming to replace regulatory obligations specific to each use case.
Data & reproducibility
Prints whose parameters and outcomes can be tracked and repeated: a prerequisite for qualification or transfer to manufacturing.
Innovation & transparency
Active R&D to advance the platform, with clear communication on system capabilities and realistic scope of use.
Contact & funding
Investors, funds, angels: reach out to explore the Inov4D case, value model, and company outlook. Industrial partners: we remain open to discussions on use cases and quality requirements.